Translational Development Acquisition Cash Flow Statement (2024-2026) | TDAC

Cash Flow Statement Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -0.00M-0.06M-0.01M1.48M1.62M1.66M1.47M1.33M
Cash from Operations (Quarter) -0.31M
Change in Working Capital
Change in Accured Expenses (Quarter) 0.02M-0.47M0.09M-0.06M0.01M-0.01M-0.01M
Other Working Capital Changes (Quarter) -0.00M0.04M
Financing Activities
Other financing activities (Quarter) 0.21M
Cash from Financing Activities (Quarter) 0.30M
Additional items
Change in Cash (Quarter) -0.01M
Free Cash Flow (Quarter) -0.31M
Net Cash Flow (Quarter) -0.01M